Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II personalized peptide vaccination for cancer
jRCTs071180058Phase 2Completed
- Start
- Nov 2008
- Modality
- Vaccines & Immunotherapeutics, Peptides
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of personalized peptide cancer vaccine in cancer. Primary endpoint: Correlation between peptide-specific antibody level and overall survival. Started Nov 2008; status: completed.
02
Drugs
personalized peptide cancer vaccine
03
Conditions
cancer
Beyond the preview
Go deeper on jRCTs071180058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180058.